Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...

BERLIN -- Adding durvalumab (Imfinzi) to bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly ...

AstraZeneca (NASDAQ:AZN) has announced positive results from a late-stage trial testing Imfinzi (durvalumab) combined with Bacillus Calmette-Guérin (BCG) therapy as a bladder cancer treatment. This ...

To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...

Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, ...

An overactive bladder can cause you to leak urine when you least expect it. You can mitigate this with simple lifestyle changes.

Overall, results show that women can effectively receive help for bladder control issues even if they can’t make it into a doctor’s office, researchers concluded.

Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, ...

CG Oncology, Inc. (NASDAQ:CGON) is one of the best healthcare stocks with the highest upside. On October 7, CG Oncology, Inc.

Deion Sanders recalled the intense pain he suffered while recovering after his bladder removal surgery during an appearance ...